Ms. O’Connell, who is in charge of the Administration for Strategic Preparedness and Response, wrote in an Aug. 30 blog post that “it has been more than 530 days since we last received new funding for COVID-19.” Because of this, she predicts the administration will be forced to forgo buying and delivering free shots by January and that the last supply of Pfizer’s antiviral treatment will dry up by mid-2023.
The supply of Evusheld, AstraZeneca’s preventative treatment, and Lagevrio, Merck’s antiviral drug, will run out by early 2023, she said.
Other free COVID-19 response measures, including at-home COVID-19 test kits, will end Sept. 2 because of the shrinking budget.
Ms. O’Connell said “additional COVID-19 funding continues to be urgently needed” for the updated boosters expected to be ready early September and other “critical response needs.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
